
Cure-in enters global medical device market with ‘MR-SON,’ an MRI-guided automated breast biopsy robot
Targeting U.S. and European markets with precision and convenience-enhancing automation PANGYO, GYEONGGI-DO, SOUTH KOREA, July 19, 2025 /EINPresswire.com/ -- Cure-in Inc. (co-CEOs Yung-Ho Jo and Samuel Byeongjun Park), a medical robotics company …